Kroh U F
Abteilung für Anästhesie und Intensivtherapie, Klinikum der Philipps-Universität Marburg, Germany.
New Horiz. 1995 Nov;3(4):748-59.
Patients with acute renal failure are commonly treated by continuous renal replacement therapies. To understand drug disposition in multiple organ failure patients, the pharmacokinetics of 18 drugs were evaluated in 243 patients. Continuous hemofiltration served as a model for constant elimination rates. In addition, the elimination of drugs was investigated during extracorporeal lung support. The dosage of 11 of 15 drugs had to be reduced as a result of these kinetic studies. Wide variability in volumes of distribution, clearances, and the extrarenal fractions of elimination were detected. There was a close correlation of the latter with Acute Physiology and Chronic Health Evaluation II scores of illness severity. A new algorithm was developed for primary estimates of drug dosage during hemofiltration and other organ support systems. Two in vitro studies confirmed the clinical results on drug sieving and provided important information on adsorption to membranes. A clinical validation study of the algorithm improved drug dosage. A simplified therapeutic drug monitoring approach is given.
急性肾衰竭患者通常采用连续性肾脏替代疗法进行治疗。为了解多器官功能衰竭患者的药物处置情况,对243例患者的18种药物的药代动力学进行了评估。持续性血液滤过作为恒定清除率的模型。此外,还研究了体外肺支持期间药物的清除情况。这些动力学研究结果显示,15种药物中有11种的剂量必须减少。检测到分布容积、清除率和肾外清除分数存在很大差异。后者与急性生理学与慢性健康状况评分II(APACHE II)疾病严重程度评分密切相关。开发了一种新算法,用于血液滤过和其他器官支持系统期间药物剂量的初步估算。两项体外研究证实了药物筛分的临床结果,并提供了关于膜吸附的重要信息。该算法的临床验证研究改善了药物剂量。给出了一种简化的治疗药物监测方法。